Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.

Registros relacionados

• Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
  por: Cull, G, et al.
  Publicado em: (2000)
• Allogeneic stem cell transplantation for lymphoproliferative disease using BEAM-Campath conditioning: An effective regime with low procedure-related toxicity.
  por: Cull, G, et al.
  Publicado em: (1999)
• T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
  por: Hale, G, et al.
  Publicado em: (1988)
• COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
  por: Fibbe, W, et al.
  Publicado em: (1993)
• Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
  por: Chakrabarti, S, et al.
  Publicado em: (2004)